Related references
Note: Only part of the references are listed.Public health insurance and cancer-specific mortality risk among patients with breast cancer: A prospective cohort study in China
Yuxin Xie et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
Balazs Gyorffy
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)
Tumor Mutational Burden and PTEN Alterations as Molecular Correlates of Response to PD-1/L1 Blockade in Metastatic Triple-Negative Breast Cancer
Romualdo Barroso-Sousa et al.
CLINICAL CANCER RESEARCH (2020)
Molecular Predictive and Prognostic Markers in Locoregional Management
Eleftherios P. Mamounas et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
alpha O-Conotoxin GeXIVA Inhibits the Growth of Breast Cancer Cells via Interaction with alpha 9 Nicotine Acetylcholine Receptors
Zhihua Sun et al.
MARINE DRUGS (2020)
Effect of low dose metronomic therapy on MCF-7 tumor cells growth and angiogenesis. Role of muscarinic acetylcholine receptors
A. R. Salem et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Single-cell RNA sequencing reveals a heterogeneous response to Glucocorticoids in breast cancer cells
Jackson A. Hoffman et al.
COMMUNICATIONS BIOLOGY (2020)
Glucocorticoids promote breast cancer metastasis
Milan M. S. Obradovic et al.
NATURE (2019)
Dexamethasone Increases Cisplatin-Loaded Nanocarrier Delivery and Efficacy in Metastatic Breast Cancer by Normalizing the Tumor Microenvironment
John D. Martin et al.
ACS NANO (2019)
Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression
Lingli He et al.
CANCER RESEARCH (2019)
Overexpression of SLC12A5 is associated with tumor progression and poor survival in ovarian carcinoma
Gui-Ping Yang et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
Epigenetic identification of ADCY4 as a biomarker for breast cancer: an integrated analysis of adenylate cyclases
Yu Fan et al.
EPIGENOMICS (2019)
Tumor mutational and indel burden: a systematic pan-cancer evaluation as prognostic biomarkers
Hao-Xiang Wu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Cholinergic Receptor Nicotinic Alpha 5 (CHRNA5) RNAi is associated with cell cycle inhibition, apoptosis, DNA damage response and drug sensitivity in breast cancer
Sahika Cingir Koker et al.
PLOS ONE (2018)
Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway
J. Y. Liu et al.
CELL DEATH & DISEASE (2017)
Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts
William D. Gwynne et al.
ONCOTARGET (2017)
Inhibitory Effects of Dopamine Receptor D1 Agonist on Mammary Tumor and Bone Metastasis
Kazumasa Minami et al.
SCIENTIFIC REPORTS (2017)
Expression and Genetic Variation in Neuroendocrine Signaling Pathways in Lethal and Nonlethal Prostate Cancer among Men Diagnosed with Localized Disease
Donghao Lu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
Donghao Lu et al.
CLINICAL CANCER RESEARCH (2016)
Increased expression of Solute carrier family 12 member 5 via gene amplification contributes to tumour progression and metastasis and associates with poor survival in colorectal cancer
Lixia Xu et al.
GUT (2016)
Aberrant nocturnal cortisol and disease progression in women with breast cancer
Jamie M. Zeitzer et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production
Vytautas Leoncikas et al.
SCIENTIFIC REPORTS (2016)
Effects of Estrogen Receptor and Human Epidermal Growth Factor Receptor-2 Levels on the Efficacy of Trastuzumab A Secondary Analysis of the HERA Trial
Sherene Loi et al.
JAMA ONCOLOGY (2016)
Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)
S. Gourgou-Bourgade et al.
ANNALS OF ONCOLOGY (2015)
Biobehavioral Approaches to Cancer Progression and Survival Mechanisms and Interventions
Susan K. Lutgendorf et al.
AMERICAN PSYCHOLOGIST (2015)
Analysis of incidence and prognosis from 'extreme' case-control designs
Agus Salim et al.
STATISTICS IN MEDICINE (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Interaction of Glucocorticoid Receptor (GR) with Estrogen Receptor (ER) α and Activator Protein 1 (AP1) in Dexamethasone-mediated Interference of ERα Activity
Sudipan Karmakar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
The sva package for removing batch effects and other unwanted variation in high-throughput experiments
Jeffrey T. Leek et al.
BIOINFORMATICS (2012)
The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data
Ethan Cerami et al.
CANCER DISCOVERY (2012)
Activation of the Glucocorticoid Receptor Is Associated with Poor Prognosis in Estrogen Receptor-Negative Breast Cancer
Deng Pan et al.
CANCER RESEARCH (2011)
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer
Erica K. Sloan et al.
CANCER RESEARCH (2010)
A scaling normalization method for differential expression analysis of RNA-seq data
Mark D. Robinson et al.
GENOME BIOLOGY (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival
Vaibhav P. Pai et al.
BREAST CANCER RESEARCH (2009)
Dopamine increases the efficacy of anticancer drugs in breast and colon cancer preclinical models
Chandrani Sarkar et al.
CLINICAL CANCER RESEARCH (2008)
Extending survival with chemotherapy in metastatic breast cancer
J O'Shaughnessy
ONCOLOGIST (2005)
A global test for groups of genes: testing association with a clinical outcome
JJ Goeman et al.
BIOINFORMATICS (2004)
Diurnal cortisol rhythm as a predictor of breast cancer survival
SE Sephton et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
